13-48362957-G-A

Variant summary

Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong

The NM_000321.3(RB1):​c.861G>A​(p.Glu287Glu) variant causes a splice region, synonymous change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).

Frequency

Genomes: not found (cov: 32)

Consequence

RB1
NM_000321.3 splice_region, synonymous

Scores

2
Splicing: ADA: 0.9997
2

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:2

Conservation

PhyloP100: 6.83

Publications

0 publications found
Variant links:
Genes affected
RB1 (HGNC:9884): (RB transcriptional corepressor 1) The protein encoded by this gene is a negative regulator of the cell cycle and was the first tumor suppressor gene found. The encoded protein also stabilizes constitutive heterochromatin to maintain the overall chromatin structure. The active, hypophosphorylated form of the protein binds transcription factor E2F1. Defects in this gene are a cause of childhood cancer retinoblastoma (RB), bladder cancer, and osteogenic sarcoma. [provided by RefSeq, Jul 2008]
RB1 Gene-Disease associations (from GenCC):
  • hereditary retinoblastoma
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics
  • retinoblastoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • melanoma
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 12 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF, max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
PP5
Variant 13-48362957-G-A is Pathogenic according to our data. Variant chr13-48362957-G-A is described in ClinVar as Pathogenic. ClinVar VariationId is 527929.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000321.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RB1
NM_000321.3
MANE Select
c.861G>Ap.Glu287Glu
splice_region synonymous
Exon 8 of 27NP_000312.2
RB1
NM_001407165.1
c.861G>Ap.Glu287Glu
splice_region synonymous
Exon 8 of 27NP_001394094.1
RB1
NM_001407166.1
c.861G>Ap.Glu287Glu
splice_region synonymous
Exon 8 of 17NP_001394095.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RB1
ENST00000267163.6
TSL:1 MANE Select
c.861G>Ap.Glu287Glu
splice_region synonymous
Exon 8 of 27ENSP00000267163.4
RB1
ENST00000467505.6
TSL:1
n.*229G>A
splice_region non_coding_transcript_exon
Exon 3 of 22ENSP00000434702.1
RB1
ENST00000467505.6
TSL:1
n.*229G>A
3_prime_UTR
Exon 3 of 22ENSP00000434702.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
30
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Retinoblastoma Pathogenic:2
Jul 22, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

For these reasons, this variant has been classified as Pathogenic. A different variant affecting this nucleotide (c.861G>C) has been determined to be pathogenic (PMID: 11317357, 26539030, 22084214). This suggests that this nucleotide is important for normal RNA splicing, and that other variants at this position may also be pathogenic. Nucleotide substitutions within the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. This variant has been reported in individuals affected with retinoblastoma, including one case of bilateral retinoblastoma in which the variant was shown to have arisen de novo (PMID: 24225018, Invitae). This variant is not present in population databases (ExAC no frequency). This sequence change affects codon 287 of the RB1 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the RB1 protein. This variant also falls at the last nucleotide of exon 8 of the RB1 coding sequence, which is part of the consensus splice site for this exon.

May 20, 2024
Genetic Diagnostic Laboratory, University of Pennsylvania School of Medicine
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Case and Pedigree Information: BILATERAL CASES:2, UNILATERAL CASES:0, TOTAL CASES:2, PEDIGREES:2. ACMG Codes Applied:PVS1, PM2, PS4SUP

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.31
CADD
Pathogenic
26
DANN
Benign
0.87
PhyloP100
6.8
Mutation Taster
=4/96
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
1.0
SpliceAI score (max)
0.74
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.74
Position offset: 48
DS_DL_spliceai
0.64
Position offset: 0

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1555284956; hg19: chr13-48937093; COSMIC: COSV57331141; COSMIC: COSV57331141; API